Radiotherapy and paclitaxel plus pazopanib or placebo in anaplastic thyroid cancer (NRG/RTOG 0912): a randomised, double-blind, placebo-controlled, multicentre, phase 2 trial
Eric J. Sherman, Jonathan Harris, Keith C. Bible, Ping Xia, Ronald Ghossein, Christine H. Chung, Nadeem Riaz, G. Brandon Gunn, Robert L. Foote, Sue S. Yom, Stuart J. Wong, Shlomo A. Koyfman, Michael Dzeda, David A. Clump, Saad A. Khan, Manisha H. Shah, Kevin P. Redmond, Pedro A. Torres‐Saavedra, Quynh‐Thu Le, Nancy Y. Lee
Topics & Concepts
MedicinePazopanibInternal medicineAnaplastic thyroid cancerPlaceboClinical endpointOncologyPopulationRadiation therapyClinical trialThyroid cancerCancerPathologyEnvironmental healthSunitinibAlternative medicineThyroid Cancer Diagnosis and TreatmentThyroid and Parathyroid SurgeryMultiple and Secondary Primary Cancers